Company Filing History:
Years Active: 2013
Title: Douglas Michael Robinson – Innovator in Cancer Treatment Biomarkers
Introduction
Douglas Michael Robinson, an innovative inventor based in Hanover, MA, has made significant contributions to the field of cancer treatment through his research on biomarkers. With one patent to his name, Robinson's work focuses on advancing therapeutic methods for those suffering from cancer, showcasing the vital intersection of biotechnology and medicine.
Latest Patents
Robinson's notable patent, titled "Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators," delves into the use of IGF1R biomarkers for identifying mammals that would respond therapeutically to cancer treatment involving IGF1R modulators. This method comprises exposing the subject to the IGF1R modulator and measuring the levels of biomarkers, ultimately enabling healthcare professionals to monitor and evaluate treatment responsiveness effectively.
Career Highlights
Currently, Douglas Michael Robinson is employed at Bristol-Myers Squibb Company, where he plays a pivotal role in research and development aimed at creating innovative solutions for cancer treatment. His expertise in the field has allowed him to contribute significantly to understanding and applying therapeutic interventions in oncology.
Collaborations
Robinson works alongside esteemed colleagues, including Fei Huang and Xia Han, fostering an environment of collaboration that is essential for groundbreaking research. These partnerships contribute to the sharing of knowledge and expertise, further enhancing the pursuit of effective cancer treatments.
Conclusion
Douglas Michael Robinson's innovative work and dedication to cancer research highlight his important role within the scientific community. Through his patent and collaborations, he continues to push the boundaries of medical science, ultimately aiming to improve therapeutic outcomes for cancer patients.